Hepatitis C Archives - Incorpore
 
Geneva:
+4122 840 33 34
 
Moscow:
+7(495)720 80 57
 

Sofosbuvir (brand name Sovaldi) is a drug developed by Gilead Sciences used to treat hepatitis C infection. In combination with other therapies, Sofosbuvir can effectively cure hepatitis in 90 percent of patients. It inhibits the RNA polymerase that the hepatitis C virus (HCV) uses to replicate its RNA. It was discovered at Pharmasset and developed

It is an infectious disease of the liver due to infection with hepatitis C virus (HCV). Hepatitis C virus is transmitted by contact with blood of an infected person. For infection with hepatitis C virus it is necessary that the material containing the virus (the blood of an infected person), gets into the bloodstream of